Skip to main content

Table 3 Association between ePVS and postoperative hypotension

From: Predictive value of estimated plasma volume for postoperative hypotension in percutaneous intramyocardial septal radiofrequency ablation treating for hypertrophic obstructive cardiomyopathy

 

Value (95% CI)

 

Continuous ePVS

Categorical ePVS 1

Categorical ePVS 2

Categorical ePVS 3

Categorical ePVS 4

Unadjusted OR

1.669 (1.299 ~ 2.144)

4.818 (2.347 ~ 9.890)

4.726 (1.662 ~ 13.442)

4.100 (2.084 ~ 8.066)

3.557 (1.96 ~ 6.454)

Adjusted OR in Model1

1.539 (1.129 ~ 2.098)

4.691 (1.993 ~ 11.042)

4.732 (1.519 ~ 14.738)

3.593 (1.585 ~ 8.142)

2.649 (1.28 ~ 5.479)

Adjusted OR in Model2

1.782 (1.368 ~ 2.323)

5.015 (2.410 ~ 10.438)

4.654 (1.62 ~ 13.373)

4.184 (2.098 ~ 8.347)

3.692 (1.997 ~ 6.826)

Adjusted OR in Model3

1.531 (1.154 ~ 2.032)

3.366 (1.559 ~ 7.265)

3.195 (1.078 ~ 9.472)

2.880 (1.382 ~ 6.001)

2.664 (1.353 ~ 5.247)

Sensitivity

-

0.811 (0.680 ~ 0.906)

0.925 (0.818 ~ 0.979)

0.774 (0.638 ~ 0.877)

0.491 (0.351 ~ 0.632)

Specialty

-

0.528 (0.475 ~ 0.582)

0.278 (0.232 ~ 0.328)

0.545 (0.492 ~ 0.598)

0.787 (0.740 ~ 0.829)

PPV

-

0.206 (0.153 ~ 0.267)

0.162 (0.122 ~ 0.208)

0.204 (0.151 ~ 0.266)

0.257 (0.176 ~ 0.354)

NPV

-

0.949 (0.908 ~ 0.975)

0.961 (0.903 ~ 0.989)

0.941 (0.900 ~ 0.969)

0.911 (0.873 ~ 0.941)

  1. Categorical ePVS 1 was converted by the best threshold in ROC curve analysis. Categorical ePVS 2~4 were converted by the first, second, and third quartile, respectively
  2. Model 1 was derived from ePVS and preassigned confounding factors including sex, age, NYHA III/IV and log-BNP; Model 2 was derived from ePVS and preassigned confounding factors including baseline diuretics usage, procedure duration time and creatinine; Model 3 was derived from ePVS and other confounding factors filtered from a global optimization search
  3. ePVS Estimated plasma volume status, PPV Positive predictive value, NPV Negative predictive value